{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:05:03Z","timestamp":1780506303040,"version":"3.54.1"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03426-2","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T20:10:04Z","timestamp":1778011804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mesoporous Silica Nanoparticles for Ocular Drug Delivery: Synthesis, Functionalization, and Safety Insights"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2375-7810","authenticated-orcid":false,"given":"Lajja","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7974-7112","authenticated-orcid":false,"given":"Tejal","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"3426_CR1","doi-asserted-by":"publisher","unstructured":"Gorantla S, Rapalli VK, Waghule T, Singh PP, Dubey SK, Saha RN, et al. Nanocarriers for ocular drug delivery\u202f: current status and translational opportunity. Royal Soc Chem. 2020;27835\u201355. https:\/\/doi.org\/10.1039\/d0ra04971a","DOI":"10.1039\/d0ra04971a"},{"key":"3426_CR2","doi-asserted-by":"publisher","unstructured":"Lambiase A, Mantelli F, Sacchetti M, Rahimi S, Massaro-giordano G. Rare Diseases of the Anterior Segment of the Eye\u202f: Update on Diagnosis and Management. Hindawi Publishing Corporation; 2015;2015. https:\/\/doi.org\/10.1155\/2015\/947326","DOI":"10.1155\/2015\/947326"},{"key":"3426_CR3","doi-asserted-by":"publisher","unstructured":"Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J [Internet]. AAPS J; 2010 [cited 2025 Dec 22];12:348\u201360. https:\/\/doi.org\/10.1208\/S12248-010-9183-3","DOI":"10.1208\/S12248-010-9183-3"},{"key":"3426_CR4","unstructured":"Purves D, Augustine GJ, Fitzpatrick D, Katz LC, LaMantia A-S, McNamara JO, et al. Anatomy of the Eye. Sinauer Associates; 2001 [cited 2025 Nov 18]; https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK11120\/. Accessed 18 Nov 2025"},{"key":"3426_CR5","doi-asserted-by":"publisher","unstructured":"Bastawrous A, Burgess PI, Mahdi AM, Kyari F, Burton MJ, Kuper H. Posterior segment eye disease in sub-Saharan Africa\u202f: review of recent population-based studies. 2014;19:600\u20139. https:\/\/doi.org\/10.1111\/tmi.12276","DOI":"10.1111\/tmi.12276"},{"key":"3426_CR6","doi-asserted-by":"publisher","unstructured":"Varela-Fern\u00e1ndez R, D\u00edaz-Tom\u00e9 V, Luaces-Rodr\u00edguez A, Conde-Penedo A, Garc\u00eda-Otero X, Luzardo-\u00e1lvarez A, et al. Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations. Pharmaceutics [Internet]. Pharmaceutics; 2020 [cited 2026 Apr 15];12. https:\/\/doi.org\/10.3390\/PHARMACEUTICS12030269","DOI":"10.3390\/PHARMACEUTICS12030269"},{"key":"3426_CR7","doi-asserted-by":"publisher","unstructured":"Li S, Chen L, Fu Y. Nanotechnology-based ocular drug delivery systems: recent advances and future prospects. Journal of Nanobiotechnology 2023 21:1 [Internet]. BioMed Central; 2023 [cited 2025 Nov 21];21:232-. https:\/\/doi.org\/10.1186\/S12951-023-01992-2","DOI":"10.1186\/S12951-023-01992-2"},{"key":"3426_CR8","doi-asserted-by":"publisher","unstructured":"Vallet-Reg\u00ed M, Colilla M, Izquierdo-Barba I, Manzano M. Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights. Molecules 2018, Vol 23, Page 47 [Internet]. Multidisciplinary Digital Publishing Institute; 2017 [cited 2025 Nov 21];23:47. https:\/\/doi.org\/10.3390\/MOLECULES23010047","DOI":"10.3390\/MOLECULES23010047"},{"key":"3426_CR9","doi-asserted-by":"publisher","unstructured":"Vaneev A, Tikhomirova V, Chesnokova N, Popova E, Beznos O, Kost O, et al. Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye. International Journal of Molecular Sciences 2021, Vol 22, Page 12368 [Internet]. Multidisciplinary Digital Publishing Institute; 2021 [cited 2025 Nov 21];22:12368. https:\/\/doi.org\/10.3390\/IJMS222212368","DOI":"10.3390\/IJMS222212368"},{"key":"3426_CR10","doi-asserted-by":"publisher","unstructured":"Khiev D, Mohamed ZA, Vichare R, Paulson R, Bhatia S, Mohapatra S, et al. Emerging Nano-Formulations and Nanomedicines Applications for Ocular Drug Delivery. Nanomaterials [Internet]. MDPI AG; 2021 [cited 2025 Nov 21];11:173. https:\/\/doi.org\/10.3390\/NANO11010173","DOI":"10.3390\/NANO11010173"},{"key":"3426_CR11","doi-asserted-by":"publisher","unstructured":"Li S, Chen L, Fu Y. Nanotechnology-based ocular drug delivery systems: recent advances and future prospects. Journal of Nanobiotechnology 2023 21:1 [Internet]. BioMed Central; 2023 [cited 2025 Nov 22];21:232-. https:\/\/doi.org\/10.1186\/S12951-023-01992-2","DOI":"10.1186\/S12951-023-01992-2"},{"key":"3426_CR12","doi-asserted-by":"publisher","unstructured":"Narayan R, Nayak UY. file:\/\/\/C:\/Users\/hp\/Desktop\/study material\/Ph.D Nirma\/MSNs\/research + review\/occular anatomy\/2020 Drug Delivery to the Posterior Segment of the Eye Biopharmaceutic and Pharmacokinetic Considerations.pdf. 2018;1\u201349. https:\/\/doi.org\/10.3390\/pharmaceutics10030118","DOI":"10.3390\/pharmaceutics10030118"},{"key":"3426_CR13","doi-asserted-by":"publisher","unstructured":"Akhter MH, Ahmad I, Alshahrani MY, Al-Harbi AI, Khalilullah H, Afzal O, et al. Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System. Gels 2022, Vol 8, Page 82 [Internet]. Multidisciplinary Digital Publishing Institute; 2022 [cited 2025 Nov 22];8:82. https:\/\/doi.org\/10.3390\/GELS8020082","DOI":"10.3390\/GELS8020082"},{"key":"3426_CR14","doi-asserted-by":"publisher","unstructured":"Lu H, Zhang S, Wang J, Chen Q. A Review on Polymer and Lipid-Based Nanocarriers and Its Application to Nano-Pharmaceutical and Food-Based Systems. Front Nutr [Internet]. Frontiers Media S.A.; 2021 [cited 2026 Feb 9];8:783831. https:\/\/doi.org\/10.3389\/fnut.2021.783831","DOI":"10.3389\/fnut.2021.783831"},{"key":"3426_CR15","doi-asserted-by":"publisher","unstructured":"Insights C. Mesoporous Silica Nanoparticles for Drug Delivery\u202f: 2018;m:1\u201319. https:\/\/doi.org\/10.3390\/molecules23010047","DOI":"10.3390\/molecules23010047"},{"key":"3426_CR16","doi-asserted-by":"publisher","unstructured":"Raj VK, Mazumder R, Madhra M. Ocular drug delivery system: Challenges and approaches. International Journal of Applied Pharmaceutics [Internet]. Innovare Academics Sciences Pvt. Ltd; 2020 [cited 2026 Apr 15];12:49\u201357. https:\/\/doi.org\/10.22159\/IJAP.2020V12I5.38762","DOI":"10.22159\/IJAP.2020V12I5.38762"},{"key":"3426_CR17","doi-asserted-by":"publisher","unstructured":"Ahmed S, Amin MM, Sayed S. Ocular Drug Delivery: a Comprehensive Review. AAPS PharmSciTech [Internet]. AAPS PharmSciTech; 2023 [cited 2025 Dec 22];24. https:\/\/doi.org\/10.1208\/S12249-023-02516-9","DOI":"10.1208\/S12249-023-02516-9"},{"key":"3426_CR18","doi-asserted-by":"publisher","unstructured":"Mofidfar M, Abdi B, Ahadian S, Mostafavi E, Desai TA, Abbasi F, et al. Drug delivery to the anterior segment of the eye: A review of current and future treatment strategies. Int J Pharm [Internet]. Elsevier B.V.; 2021 [cited 2025 Nov 22];607:120924. https:\/\/doi.org\/10.1016\/J.IJPHARM.2021.120924","DOI":"10.1016\/J.IJPHARM.2021.120924"},{"key":"3426_CR19","doi-asserted-by":"publisher","unstructured":"Giri BR, Jakka D, Sandoval MA, Kulkarni VR, Bao Q. Advancements in Ocular Therapy: A Review of Emerging Drug Delivery Approaches and Pharmaceutical Technologies. Pharmaceutics [Internet]. Multidisciplinary Digital Publishing Institute (MDPI); 2024 [cited 2025 Nov 22];16:1325. https:\/\/doi.org\/10.3390\/PHARMACEUTICS16101325\/S1","DOI":"10.3390\/PHARMACEUTICS16101325\/S1"},{"key":"3426_CR20","doi-asserted-by":"publisher","unstructured":"Achouri D, Alhanout K, Piccerelle P, Andrieu V. Recent advances in ocular drug delivery. 2012;1\u201319. https:\/\/doi.org\/10.3109\/03639045.2012.736515","DOI":"10.3109\/03639045.2012.736515"},{"key":"3426_CR21","doi-asserted-by":"publisher","unstructured":"Linda A, Sherridan C, Sabastine O, Chidiebere A, Precious C, Amarachi S, et al. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases. Journal of Controlled Release. Elsevier B.V.; 2023;354:465\u201388. https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.018","DOI":"10.1016\/j.jconrel.2023.01.018"},{"key":"3426_CR22","doi-asserted-by":"publisher","unstructured":"Li S, Chen L, Fu Y. Nanotechnology - based ocular drug delivery systems\u202f: recent advances and future prospects. J Nanobiotechnology. BioMed Central; 2023;1\u201339. https:\/\/doi.org\/10.1186\/s12951-023-01992-2","DOI":"10.1186\/s12951-023-01992-2"},{"key":"3426_CR23","doi-asserted-by":"publisher","unstructured":"Alhowyan AA, Kalam MA, Iqbal M, Raish M, El-Toni AM, Alkholief M, et al. Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies. Molecules [Internet]. MDPI; 2023 [cited 2026 Feb 8];28:1260. https:\/\/doi.org\/10.3390\/molecules28031260","DOI":"10.3390\/molecules28031260"},{"key":"3426_CR24","doi-asserted-by":"publisher","unstructured":"Hu C, Sun J, Zhang Y, Chen J, Lei Y, Sun X. Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma. 2020;1801047:1\u201310. https:\/\/doi.org\/10.1002\/adhm.201801047","DOI":"10.1002\/adhm.201801047"},{"key":"3426_CR25","doi-asserted-by":"publisher","unstructured":"Iqbal H, Razzaq A, Zhou D, Lou J, Xiao R. Materials Today Bio Nanomedicine in glaucoma treatment\u202f; Current challenges and future perspectives. Mater Today Bio. Elsevier Ltd; 2024;28:101229. https:\/\/doi.org\/10.1016\/j.mtbio.2024.101229","DOI":"10.1016\/j.mtbio.2024.101229"},{"key":"3426_CR26","doi-asserted-by":"publisher","unstructured":"Weinreb RN, Aung T, Medeiros FA. The Pathophysiology and Treatment of Glaucoma: A Review. JAMA [Internet]. American Medical Association; 2014 [cited 2025 Nov 22];311:1901. https:\/\/doi.org\/10.1001\/JAMA.2014.3192","DOI":"10.1001\/JAMA.2014.3192"},{"key":"3426_CR27","doi-asserted-by":"publisher","unstructured":"Kundu S, Kumari G, Srinivasarao DA. Emerging drug delivery strategies for glaucoma therapy: focus on nanoparticles and stimuli-responsive systems. RSC Pharmaceutics [Internet]. RSC; 2025 [cited 2025 Dec 22];2:1050\u201377. https:\/\/doi.org\/10.1039\/D5PM00068H","DOI":"10.1039\/D5PM00068H"},{"key":"3426_CR28","doi-asserted-by":"publisher","unstructured":"Paiva MRB, Andrade GF, Dourado LFN, Castro BFM, Fialho SL, Sousa EMB, et al. Surface functionalized mesoporous silica nanoparticles for intravitreal application of tacrolimus. J Biomater Appl [Internet]. SAGE Publications Ltd; 2021 [cited 2026 Feb 8];35:1019\u201333. https:\/\/doi.org\/10.1177\/0885328220977605","DOI":"10.1177\/0885328220977605"},{"key":"3426_CR29","doi-asserted-by":"publisher","unstructured":"Baghban R, Bamdad S, Attar A, Mortazavi M. Implications of nanotechnology for the treatment of Dry Eye Disease: Recent advances. Int J Pharm [Internet]. Elsevier; 2025 [cited 2025 Dec 22];672:125355. https:\/\/doi.org\/10.1016\/J.IJPHARM.2025.125355","DOI":"10.1016\/J.IJPHARM.2025.125355"},{"key":"3426_CR30","unstructured":"Recent Advances in Nanotechnology for the Treatment of Dry Eye Disease G, Buffon G, Taloni A, Giannaccare G. Recent Advances in Nanotechnology for the Treatment of Dry Eye Disease. 2024;1\u201325."},{"key":"3426_CR31","doi-asserted-by":"publisher","unstructured":"Andrade GF, Fernanda L, Dourado N, Fernanda B, Castro M, Lig S. Surface functionalized mesoporous silica nanoparticles for intravitreal application of tacrolimus. 2020; https:\/\/doi.org\/10.1177\/0885328220977605","DOI":"10.1177\/0885328220977605"},{"key":"3426_CR32","doi-asserted-by":"publisher","unstructured":"Johari MK, Baghban R, Salari R, Attar A. Revolutionizing uveitis treatment with nanotechnology: Innovations, barriers, and strategic solutions. Biomedicine & Pharmacotherapy [Internet]. Elsevier Masson; 2026 [cited 2026 Feb 8];194:118911. https:\/\/doi.org\/10.1016\/j.biopha.2025.118911","DOI":"10.1016\/j.biopha.2025.118911"},{"key":"3426_CR33","doi-asserted-by":"publisher","unstructured":"Ambekar A, Sahoo J, Singh K. Breaking barriers in ocular drug delivery for Uveitis: Advanced drug delivery systems, challenges and future prospects. Exp Eye Res [Internet]. Academic Press; 2025 [cited 2025 Dec 22];257:110456. https:\/\/doi.org\/10.1016\/J.EXER.2025.110456","DOI":"10.1016\/J.EXER.2025.110456"},{"key":"3426_CR34","doi-asserted-by":"publisher","unstructured":"Wu X, Hu M, Cai Y, Jia F, Ye Y, Yu N, et al. Nano-based drug delivery systems for the treatment of non-infectious uveitis. Advances in Ophthalmology Practice and Research [Internet]. Elsevier Inc.; 2024 [cited 2025 Dec 22];5:124. https:\/\/doi.org\/10.1016\/J.AOPR.2024.11.003","DOI":"10.1016\/J.AOPR.2024.11.003"},{"key":"3426_CR35","doi-asserted-by":"publisher","unstructured":"Agrawal R V., Murthy S, Sangwan V, Biswas J. Current approach in diagnosis and management of anterior uveitis. Indian J Ophthalmol [Internet]. Indian J Ophthalmol; 2010 [cited 2025 Nov 22];58:11\u20139. https:\/\/doi.org\/10.4103\/0301-4738.58468","DOI":"10.4103\/0301-4738.58468"},{"key":"3426_CR36","doi-asserted-by":"publisher","unstructured":"Pleyer U, Pohlmann D, Rademacher J. [Anterior Uveitis: Clinic, Diagnostic Procedure and Treatment Options]. Klin Monbl Augenheilkd [Internet]. Klin Monbl Augenheilkd; 2020 [cited 2025 Nov 22];237:1005\u201319. https:\/\/doi.org\/10.1055\/A-1148-2875","DOI":"10.1055\/A-1148-2875"},{"key":"3426_CR37","doi-asserted-by":"publisher","unstructured":"Chen Y, Ye Z, Chen H, Li Z. Breaking Barriers: Nanomedicine-Based Drug Delivery for Cataract Treatment. Int J Nanomedicine [Internet]. Dove Medical Press Ltd; 2024 [cited 2026 Feb 8];19:4021. https:\/\/doi.org\/10.2147\/IJN.S463679","DOI":"10.2147\/IJN.S463679"},{"key":"3426_CR38","doi-asserted-by":"publisher","unstructured":"Chen Y, Ye Z, Chen H, Li Z. Breaking Barriers: Nanomedicine-Based Drug Delivery for Cataract Treatment. Int J Nanomedicine [Internet]. Dove Medical Press Ltd; 2024 [cited 2025 Dec 22];19:4021. https:\/\/doi.org\/10.2147\/IJN.S463679","DOI":"10.2147\/IJN.S463679"},{"key":"3426_CR39","doi-asserted-by":"publisher","unstructured":"Cetinel S, Montemagno C. Nanotechnology for the Prevention and Treatment of Cataract. 2015;4:381\u20137. https:\/\/doi.org\/10.1097\/APO.0000000000000156","DOI":"10.1097\/APO.0000000000000156"},{"key":"3426_CR40","doi-asserted-by":"publisher","unstructured":"Ang MJ, Afshari NA. Cataract and systemic disease: A review. Clin Exp Ophthalmol [Internet]. Clin Exp Ophthalmol; 2021 [cited 2025 Nov 22];49:118\u201327. https:\/\/doi.org\/10.1111\/CEO.13892","DOI":"10.1111\/CEO.13892"},{"key":"3426_CR41","doi-asserted-by":"publisher","unstructured":"Yang J, Gong X, Fang L, Fan Q, Cai L, Qiu X, et al. Potential of CeCl3@mSiO2 nanoparticles in alleviating diabetic cataract development and progression. Nanomedicine [Internet]. Elsevier Inc.; 2017 [cited 2026 Feb 11];13:1147\u201355. https:\/\/doi.org\/10.1016\/j.nano.2016.12.021","DOI":"10.1016\/j.nano.2016.12.021"},{"key":"3426_CR42","doi-asserted-by":"publisher","unstructured":"Gu L, Li C, Lin J, Wang Q, Yin M, Zhang L, et al. Drug-loaded mesoporous carbon with sustained drug release capacity and enhanced antifungal activity to treat fungal keratitis. Biomaterials Advances [Internet]. Elsevier Ltd; 2022 [cited 2026 Feb 8];136. https:\/\/doi.org\/10.1016\/j.bioadv.2022.212771","DOI":"10.1016\/j.bioadv.2022.212771"},{"key":"3426_CR43","doi-asserted-by":"publisher","unstructured":"Xiao Y, Xi Y. Nanoparticle-based drug delivery systems\u202f: An updated strategy for treating fungal keratitis. 2024;61. https:\/\/doi.org\/10.1016\/j.colcom.2024.100794","DOI":"10.1016\/j.colcom.2024.100794"},{"key":"3426_CR44","doi-asserted-by":"publisher","unstructured":"Awad R, Ghaith AA, Awad K, Saad MM, Elmassry AA. Fungal Keratitis: Diagnosis, Management, and Recent Advances. Clin Ophthalmol [Internet]. Dove Medical Press Ltd; 2024 [cited 2026 Apr 15];18:85. https:\/\/doi.org\/10.2147\/OPTH.S447138","DOI":"10.2147\/OPTH.S447138"},{"key":"3426_CR45","doi-asserted-by":"publisher","unstructured":"Gohil U, Chandarana C, Prajapati P, Prajapati B. Polymeric Nanoparticles in Ophthalmology: A Comprehensive Review of Therapeutic Applications. BioNanoScience 2024 15:1 [Internet]. Springer; 2024 [cited 2025 Dec 22];15:151-. https:\/\/doi.org\/10.1007\/S12668-024-01631-6","DOI":"10.1007\/S12668-024-01631-6"},{"key":"3426_CR46","doi-asserted-by":"publisher","unstructured":"Eleraky NE, Attia MA, Safwat MA. Journal of Drug Delivery Science and Technology Sertaconazole-PLGA nanoparticles for management of ocular keratitis. J Drug Deliv Sci Technol. Elsevier B.V.; 2024;95:105539. https:\/\/doi.org\/10.1016\/j.jddst.2024.105539","DOI":"10.1016\/j.jddst.2024.105539"},{"key":"3426_CR47","doi-asserted-by":"publisher","unstructured":"Mellado F, Rojas T, Cumsille C. [Fungal keratitis: review of diagnosis and treatment]. Arq Bras Oftalmol [Internet]. Arq Bras Oftalmol; 2013 [cited 2025 Nov 23];76:52\u20136. https:\/\/doi.org\/10.1590\/S0004-27492013000100016","DOI":"10.1590\/S0004-27492013000100016"},{"key":"3426_CR48","doi-asserted-by":"publisher","unstructured":"Liu Y-C, Lin MT-Y, Herr A, Ng C, Wong TT, Mehta JS. pharmaceuticals Nanotechnology for the Treatment of Allergic Conjunctival Diseases. [cited 2026 Feb 8]; https:\/\/doi.org\/10.3390\/ph13110351","DOI":"10.3390\/ph13110351"},{"key":"3426_CR49","doi-asserted-by":"publisher","unstructured":"Liu YC, Lin MTY, Ng AHC, Wong TT, Mehta JS. Nanotechnology for the Treatment of Allergic Conjunctival Diseases. Pharmaceuticals [Internet]. MDPI AG; 2020 [cited 2025 Dec 22];13:351. https:\/\/doi.org\/10.3390\/PH13110351","DOI":"10.3390\/PH13110351"},{"key":"3426_CR50","doi-asserted-by":"publisher","unstructured":"Liu YC, Lin MTY, Ng AHC, Wong TT, Mehta JS. Nanotechnology for the Treatment of Allergic Conjunctival Diseases. Pharmaceuticals [Internet]. MDPI AG; 2020 [cited 2026 Apr 15];13:351. https:\/\/doi.org\/10.3390\/PH13110351","DOI":"10.3390\/PH13110351"},{"key":"3426_CR51","doi-asserted-by":"publisher","unstructured":"Azari AA, Arabi A. Conjunctivitis: A Systematic Review. J Ophthalmic Vis Res [Internet]. Knowledge E; 2020 [cited 2025 Nov 23];15:372. https:\/\/doi.org\/10.18502\/JOVR.V15I3.7456","DOI":"10.18502\/JOVR.V15I3.7456"},{"key":"3426_CR52","doi-asserted-by":"publisher","unstructured":"Sun JG, Jiang Q, Zhang XP, Shan K, Liu BH, Zhao C, et al. Mesoporous silica nanoparticles as a delivery system for improving antiangiogenic therapy. Int J Nanomedicine [Internet]. Dove Medical Press Ltd.; 2019 [cited 2026 Jan 18];14:1489. https:\/\/doi.org\/10.2147\/IJN.S195504","DOI":"10.2147\/IJN.S195504"},{"key":"3426_CR53","doi-asserted-by":"publisher","unstructured":"Elbedwehy AM, Wu J, Na HK, Baek A, Jung H, Kwon IH, et al. ROS-responsive charge reversal mesoporous silica nanoparticles as promising drug delivery system for neovascular retinal diseases. Journal of Controlled Release [Internet]. Elsevier; 2024 [cited 2026 Feb 8];373:224\u201339. https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.022","DOI":"10.1016\/j.jconrel.2024.07.022"},{"key":"3426_CR54","doi-asserted-by":"publisher","unstructured":"Yang B, Li G, Liu J, Li X, Zhang S, Sun F, et al. Nanotechnology for Age-Related Macular Degeneration. Pharmaceutics [Internet]. MDPI; 2021 [cited 2026 Apr 15];13:2035. https:\/\/doi.org\/10.3390\/PHARMACEUTICS13122035","DOI":"10.3390\/PHARMACEUTICS13122035"},{"key":"3426_CR55","doi-asserted-by":"publisher","unstructured":"Fleckenstein M, Schmitz-Valckenberg S, Chakravarthy U. Age-Related Macular Degeneration: A Review. JAMA [Internet]. JAMA; 2024 [cited 2025 Nov 23];331:147\u201357. https:\/\/doi.org\/10.1001\/JAMA.2023.26074","DOI":"10.1001\/JAMA.2023.26074"},{"key":"3426_CR56","doi-asserted-by":"publisher","unstructured":"Sun JG, Jiang Q, Zhang XP, Shan K, Liu BH, Zhao C, et al. Mesoporous silica nanoparticles as a delivery system for improving antiangiogenic therapy. Int J Nanomedicine [Internet]. Int J Nanomedicine; 2019 [cited 2025 Nov 23];14:1489\u2013501. https:\/\/doi.org\/10.2147\/IJN.S195504","DOI":"10.2147\/IJN.S195504"},{"key":"3426_CR57","doi-asserted-by":"publisher","unstructured":"Baghban R, Namvar E, Attar A, Mortazavi M. Biomedicine & Pharmacotherapy Progressing nanotechnology to improve diagnosis and targeted therapy of Diabetic Retinopathy. Biomedicine & Pharmacotherapy. Elsevier Masson SAS; 2025;183:117786. https:\/\/doi.org\/10.1016\/j.biopha.2024.117786","DOI":"10.1016\/j.biopha.2024.117786"},{"key":"3426_CR58","doi-asserted-by":"publisher","unstructured":"Morya AK, Ramesh PV, Nishant P, Kaur K, Gurnani B, Heda A, et al. Diabetic retinopathy: A review on its pathophysiology and novel treatment modalities. World J Methodol [Internet]. Baishideng Publishing Group Inc.; 2024 [cited 2025 Nov 23];14:95881. https:\/\/doi.org\/10.5662\/WJM.V14.I4.95881","DOI":"10.5662\/WJM.V14.I4.95881"},{"key":"3426_CR59","doi-asserted-by":"publisher","unstructured":"Jo DH, Kim JH, Yu YS, Lee TG, Kim JH. Antiangiogenic effect of silicate nanoparticle on retinal neovascularization induced by vascular endothelial growth factor. Nanomedicine. Elsevier Inc.; 2012;8:784\u201391. https:\/\/doi.org\/10.1016\/j.nano.2011.09.003","DOI":"10.1016\/j.nano.2011.09.003"},{"key":"3426_CR60","doi-asserted-by":"publisher","unstructured":"Xu L, Chen ZA, Wu CH, Chen YP, Wu SH, Mou CY, et al. Dual-functionalized mesoporous silica nanoparticles for topical axitinib delivery to the posterior eye segment. European Journal of Pharmaceutical Sciences [Internet]. Elsevier; 2026 [cited 2026 Feb 8];217:107398. https:\/\/doi.org\/10.1016\/j.ejps.2025.107398","DOI":"10.1016\/j.ejps.2025.107398"},{"key":"3426_CR61","doi-asserted-by":"publisher","unstructured":"Umar M, Gohar UF, Chen H. Mesoporous Umar and Asad.pdf. https:\/\/doi.org\/10.4172\/2329-6631.1000174","DOI":"10.4172\/2329-6631.1000174"},{"key":"3426_CR62","doi-asserted-by":"publisher","unstructured":"Janagam DR, Wu L, Lowe TL. Nanoparticles for drug delivery to the anterior segment of the eye. Adv Drug Deliv Rev. Elsevier B.V.; 2017;122:31\u201364. https:\/\/doi.org\/10.1016\/j.addr.2017.04.001","DOI":"10.1016\/j.addr.2017.04.001"},{"key":"3426_CR63","doi-asserted-by":"publisher","unstructured":"Djayanti K, Maharjan P, Cho KH, Jeong S, Kim MS, Shin MC, et al. Mesoporous Silica Nanoparticles as a Potential Nanoplatform: Therapeutic Applications and Considerations. Int J Mol Sci [Internet]. Int J Mol Sci; 2023 [cited 2026 Apr 15];24. https:\/\/doi.org\/10.3390\/IJMS24076349","DOI":"10.3390\/IJMS24076349"},{"key":"3426_CR64","doi-asserted-by":"publisher","unstructured":"Kolimi P, Narala S, Adel A, Youssef A, Nyavanandi D, Dudhipala N. Nanotheranostics A systemic review on development of mesoporous nanoparticles as a vehicle for transdermal drug delivery. 2023;7. https:\/\/doi.org\/10.7150\/ntno.77395","DOI":"10.7150\/ntno.77395"},{"key":"3426_CR65","doi-asserted-by":"publisher","unstructured":"Ghafoorianfar S, Ghorani-azam A, Ahmad S, Farzin D. Journal of Drug Delivery Science and Technology Efficiency of nanoparticles for treatment of ocular infections\u202f: Systematic literature review. J Drug Deliv Sci Technol. Elsevier; 2020;57:101765. https:\/\/doi.org\/10.1016\/j.jddst.2020.101765","DOI":"10.1016\/j.jddst.2020.101765"},{"key":"3426_CR66","doi-asserted-by":"publisher","unstructured":"Rastegari E, Hsiao YJ, Lai WY, Lai YH, Yang TC, Chen SJ, et al. An Update on Mesoporous Silica Nanoparticle Applications in Nanomedicine. Pharmaceutics 2021, Vol 13, Page 1067 [Internet]. Multidisciplinary Digital Publishing Institute; 2021 [cited 2025 Nov 27];13:1067. https:\/\/doi.org\/10.3390\/PHARMACEUTICS13071067","DOI":"10.3390\/PHARMACEUTICS13071067"},{"key":"3426_CR67","doi-asserted-by":"publisher","unstructured":"Han Y, Zhang L, Yang W. Synthesis of Mesoporous Silica Using the Sol\u2013Gel Approach: Adjusting Architecture and Composition for Novel Applications. Nanomaterials [Internet]. Multidisciplinary Digital Publishing Institute (MDPI); 2024 [cited 2025 Nov 23];14:903. https:\/\/doi.org\/10.3390\/NANO14110903","DOI":"10.3390\/NANO14110903"},{"key":"3426_CR68","doi-asserted-by":"publisher","unstructured":"Han Y, Zhang L, Yang W. Synthesis of Mesoporous Silica Using the Sol\u2013Gel Approach: Adjusting Architecture and Composition for Novel Applications. Nanomaterials 2024, Vol 14, Page 903 [Internet]. Multidisciplinary Digital Publishing Institute; 2024 [cited 2025 Dec 22];14:903. https:\/\/doi.org\/10.3390\/NANO14110903","DOI":"10.3390\/NANO14110903"},{"key":"3426_CR69","doi-asserted-by":"publisher","unstructured":"Olivieri F, Castaldo R, Cocca M, Gentile G, Lavorgna M. Mesoporous silica nanoparticles as carriers of active agents for smart anticorrosive organic coatings: a critical review. Nanoscale [Internet]. Royal Society of Chemistry; 2021 [cited 2025 Nov 27];13:9091\u2013111. https:\/\/doi.org\/10.1039\/D1NR01899J","DOI":"10.1039\/D1NR01899J"},{"key":"3426_CR70","doi-asserted-by":"publisher","unstructured":"Zhang H, Xu H, Wu M, Zhong Y, Wang D, Jiao Z. A soft\u2013hard template approach towards hollow mesoporous silica nanoparticles with rough surfaces for controlled drug delivery and protein adsorption. J Mater Chem B [Internet]. The Royal Society of Chemistry; 2015 [cited 2025 Nov 23];3:6480\u20139. https:\/\/doi.org\/10.1039\/C5TB00634A","DOI":"10.1039\/C5TB00634A"},{"key":"3426_CR71","doi-asserted-by":"publisher","unstructured":"Narayan R, Nayak UY, Raichur AM, Garg S. Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances. Pharmaceutics 2018, Vol 10, Page 118 [Internet]. Multidisciplinary Digital Publishing Institute; 2018 [cited 2025 Dec 22];10:118. https:\/\/doi.org\/10.3390\/PHARMACEUTICS10030118","DOI":"10.3390\/PHARMACEUTICS10030118"},{"key":"3426_CR72","doi-asserted-by":"publisher","unstructured":"Mahmoodi M, Behzad-Behbahani A, Sharifzadeh S, Abolmaali SS, Tamaddon AM. Co\u2010condensation synthesis of well\u2010defined mesoporous silica nanoparticles: effect of surface chemical modification on plasmid DNA condensation and transfection. IET Nanobiotechnol [Internet]. Institution of Engineering and Technology; 2017 [cited 2025 Nov 23];11:995. https:\/\/doi.org\/10.1049\/IET-NBT.2017.0078","DOI":"10.1049\/IET-NBT.2017.0078"},{"key":"3426_CR73","doi-asserted-by":"publisher","unstructured":"Zhou J, Liu C, Zhong Y, Luo Z, Wu L. A Review of Current Developments in Functionalized Mesoporous Silica Nanoparticles: From Synthesis to Biosensing Applications. Biosensors 2024, Vol 14, Page 575 [Internet]. Multidisciplinary Digital Publishing Institute; 2024 [cited 2025 Dec 22];14:575. https:\/\/doi.org\/10.3390\/BIOS14120575","DOI":"10.3390\/BIOS14120575"},{"key":"3426_CR74","doi-asserted-by":"publisher","unstructured":"Gu L, Zhang A, Hou K, Dai C, Zhang S, Liu M, et al. One-pot hydrothermal synthesis of mesoporous silica nanoparticles using formaldehyde as growth suppressant. Microporous and Mesoporous Materials [Internet]. Elsevier; 2012 [cited 2025 Nov 23];152:9\u201315. https:\/\/doi.org\/10.1016\/J.MICROMESO.2011.11.047","DOI":"10.1016\/J.MICROMESO.2011.11.047"},{"key":"3426_CR75","doi-asserted-by":"publisher","unstructured":"de Gre\u00f1u BD, de los Reyes R, Costero AM, Amor\u00f3s P, Ros-Lis JV. Recent Progress of Microwave-Assisted Synthesis of Silica Materials. Nanomaterials [Internet]. MDPI AG; 2020 [cited 2025 Nov 23];10:1092. https:\/\/doi.org\/10.3390\/NANO10061092","DOI":"10.3390\/NANO10061092"},{"key":"3426_CR76","doi-asserted-by":"publisher","unstructured":"Jiang SD, Tang G, Bai Z, Pan Y. Ultrasonic-assisted synthesis of hollow mesoporous silica as a toxic gases suppressant. Mater Lett [Internet]. North-Holland; 2019 [cited 2025 Nov 23];247:139\u201342. https:\/\/doi.org\/10.1016\/J.MATLET.2019.03.113","DOI":"10.1016\/J.MATLET.2019.03.113"},{"key":"3426_CR77","doi-asserted-by":"publisher","unstructured":"Liu H, Ji S, Yang H, Zhang H, Tang M. Ultrasonic-assisted ultra-rapid synthesis of monodisperse meso-SiO2@Fe3O4 microspheres with enhanced mesoporous structure. Ultrason Sonochem [Internet]. Elsevier; 2014 [cited 2025 Nov 23];21:505\u201312. https:\/\/doi.org\/10.1016\/J.ULTSONCH.2013.08.010","DOI":"10.1016\/J.ULTSONCH.2013.08.010"},{"key":"3426_CR78","doi-asserted-by":"publisher","unstructured":"Mahoney L, Koodali RT. Versatility of Evaporation-Induced Self-Assembly (EISA) Method for Preparation of Mesoporous TiO2 for Energy and Environmental Applications. Materials 2014, Vol 7, Pages 2697-2746 [Internet]. Multidisciplinary Digital Publishing Institute; 2014 [cited 2025 Nov 23];7:2697\u2013746. https:\/\/doi.org\/10.3390\/MA7042697","DOI":"10.3390\/MA7042697"},{"key":"3426_CR79","doi-asserted-by":"publisher","unstructured":"Kumar S, Malik MM, Purohit R. Synthesis Methods of Mesoporous Silica Materials. Mater Today Proc. Elsevier Ltd; 2017;4:350\u20137. https:\/\/doi.org\/10.1016\/J.MATPR.2017.01.032","DOI":"10.1016\/J.MATPR.2017.01.032"},{"key":"3426_CR80","doi-asserted-by":"publisher","unstructured":"Tang F, Li L, Chen D. Mesoporous silica nanoparticles: Synthesis, biocompatibility and drug delivery. Advanced Materials [Internet]. John Wiley & Sons, Ltd; 2012 [cited 2026 Jan 15];24:1504\u201334. https:\/\/doi.org\/10.1002\/ADMA.201104763;REQUESTEDJOURNAL:JOURNAL:15214095;WGROUP:STRING:PUBLICATION","DOI":"10.1002\/ADMA.201104763;REQUESTEDJOURNAL:JOURNAL:15214095;WGROUP:STRING:PUBLICATION"},{"key":"3426_CR81","doi-asserted-by":"publisher","unstructured":"Khalbas AH, Albayati TM, Cata NM, Zendehboudi S, Salih IK, Tofah ML. Journal of Drug Delivery Science and Technology Insights into drug loading techniques with mesoporous silica nanoparticles\u202f: Optimization of operating conditions and assessment of drug stability. J Drug Deliv Sci Technol. Elsevier B.V.; 2024;96:105698. https:\/\/doi.org\/10.1016\/j.jddst.2024.105698","DOI":"10.1016\/j.jddst.2024.105698"},{"key":"3426_CR82","doi-asserted-by":"publisher","unstructured":"Benk\u0151 F, Krist\u00f3 K, Sov\u00e1ny T. Mesoporous Silica Nanoparticles as Drug Delivery Systems. Pharmaceuticals 2025, Vol 18, Page 1392 [Internet]. Multidisciplinary Digital Publishing Institute; 2025 [cited 2025 Nov 23];18:1392. https:\/\/doi.org\/10.3390\/PH18091392","DOI":"10.3390\/PH18091392"},{"key":"3426_CR83","doi-asserted-by":"publisher","unstructured":"Alhowyan AA, Kalam MA, Iqbal M, Raish M, El-Toni AM, Alkholief M, et al. Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies. Molecules 2023, Vol 28, [Internet]. Multidisciplinary Digital Publishing Institute; 2023 [cited 2026 Apr 16];28. https:\/\/doi.org\/10.3390\/MOLECULES28031260","DOI":"10.3390\/MOLECULES28031260"},{"key":"3426_CR84","doi-asserted-by":"publisher","unstructured":"Wani A, Muthuswamy E, Savithra GHL, Mao G, Brock S, Oupick\u00fd D. Surface functionalization of mesoporous silica nanoparticles controls loading and release behavior of mitoxantrone. Pharm Res. 2012;29:2407\u201318. https:\/\/doi.org\/10.1007\/S11095-012-0766-9","DOI":"10.1007\/S11095-012-0766-9"},{"key":"3426_CR85","doi-asserted-by":"publisher","unstructured":"Castillo RR, Lozano D, Gonz\u00e1lez B, Manzano M. Europe PMC Funders Group Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery\u202f: an update. 2020;16:415\u201339. https:\/\/doi.org\/10.1080\/17425247.2019.1598375.Advances","DOI":"10.1080\/17425247.2019.1598375.Advances"},{"key":"3426_CR86","doi-asserted-by":"publisher","unstructured":"Lai CF, Shiau FJ. Enhanced and Extended Ophthalmic Drug Delivery by pH-Triggered Drug-Eluting Contact Lenses with Large-Pore Mesoporous Silica Nanoparticles. ACS Appl Mater Interfaces [Internet]. American Chemical Society; 2023 [cited 2026 Jan 25];15:18630\u20138. https:\/\/doi.org\/10.1021\/ACSAMI.2C22860","DOI":"10.1021\/ACSAMI.2C22860"},{"key":"3426_CR87","doi-asserted-by":"publisher","unstructured":"Salve R, Kumar P, Ngamcherdtrakul W, Gajbhiye V, Yantasee W. Stimuli-responsive mesoporous silica nanoparticles: A custom-tailored next generation approach in cargo delivery. Materials Science and Engineering: C [Internet]. Elsevier; 2021 [cited 2025 Nov 23];124:112084. https:\/\/doi.org\/10.1016\/J.MSEC.2021.112084","DOI":"10.1016\/J.MSEC.2021.112084"},{"key":"3426_CR88","doi-asserted-by":"publisher","unstructured":"Elbedwehy AM, Wu J, Na HK, Baek A, Jung H, Kwon IH, et al. ROS-responsive charge reversal mesoporous silica nanoparticles as promising drug delivery system for neovascular retinal diseases. Journal of Controlled Release. Elsevier B.V.; 2024;373:224\u201339. https:\/\/doi.org\/10.1016\/J.JCONREL.2024.07.022","DOI":"10.1016\/J.JCONREL.2024.07.022"},{"key":"3426_CR89","doi-asserted-by":"publisher","unstructured":"Song Y, Li Y, Xu Q, Liu Z. Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook. Int J Nanomedicine [Internet]. Dove Medical Press Ltd.; 2016 [cited 2025 Nov 23];12:87. https:\/\/doi.org\/10.2147\/IJN.S117495","DOI":"10.2147\/IJN.S117495"},{"key":"3426_CR90","doi-asserted-by":"publisher","unstructured":"Yang Y, Chen F, Xu N, Yao Q, Wang R, Xie X, et al. Red-light-triggered self-destructive mesoporous silica nanoparticles for cascade-amplifying chemo-photodynamic therapy favoring antitumor immune responses. Biomaterials [Internet]. Elsevier Ltd; 2022 [cited 2025 Nov 23];281. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121368","DOI":"10.1016\/j.biomaterials.2022.121368"},{"key":"3426_CR91","doi-asserted-by":"publisher","unstructured":"Du M, Chen Y, Tu J, Liufu C, Yu J, Yuan Z, et al. Ultrasound Responsive Magnetic Mesoporous Silica Nanoparticle-Loaded Microbubbles for Efficient Gene Delivery. ACS Biomater Sci Eng [Internet]. ACS Biomater Sci Eng; 2020 [cited 2025 Nov 23];6:2904\u201312. https:\/\/doi.org\/10.1021\/ACSBIOMATERIALS.0C00014","DOI":"10.1021\/ACSBIOMATERIALS.0C00014"},{"key":"3426_CR92","doi-asserted-by":"publisher","unstructured":"Moodley T, Singh M. Current Stimuli-Responsive Mesoporous Silica Nanoparticles for Cancer Therapy. Pharmaceutics [Internet]. MDPI AG; 2021 [cited 2025 Nov 23];13:71. https:\/\/doi.org\/10.3390\/PHARMACEUTICS13010071","DOI":"10.3390\/PHARMACEUTICS13010071"},{"key":"3426_CR93","doi-asserted-by":"publisher","unstructured":"Castillo RR, Lozano D, Gonz\u00e1lez B, Manzano M, Izquierdo-Barba I, Vallet-Reg\u00ed M. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update. Expert Opin Drug Deliv [Internet]. Taylor and Francis Ltd; 2019 [cited 2025 Nov 23];16:415. https:\/\/doi.org\/10.1080\/17425247.2019.1598375","DOI":"10.1080\/17425247.2019.1598375"},{"key":"3426_CR94","doi-asserted-by":"publisher","unstructured":"Lin X, Zhou Y, Lv K, Wu W, Chen C. Nanomedicine-Based Ophthalmic Drug Delivery Systems for the Treatment of Ocular Diseases. Int J Nanomedicine [Internet]. Dove Medical Press Ltd; 2025 [cited 2025 Dec 22];20:9221\u201349. https:\/\/doi.org\/10.2147\/IJN.S532074;WEBSITE:WEBSITE:TFOPB;PAGEGROUP:STRING:PUBLICATION","DOI":"10.2147\/IJN.S532074;WEBSITE:WEBSITE:TFOPB;PAGEGROUP:STRING:PUBLICATION"},{"key":"3426_CR95","doi-asserted-by":"publisher","unstructured":"Liao Y, Lee C, Chen S, Lai J, Wu KC. Gelatin-functionalized mesoporous silica nanoparticles with sustained release properties for intracameral pharmacotherapy of glaucoma. J Mater Chem B. Royal Society of Chemistry; 2017;5:7008\u201313. https:\/\/doi.org\/10.1039\/C7TB01217A","DOI":"10.1039\/C7TB01217A"},{"key":"3426_CR96","doi-asserted-by":"publisher","unstructured":"Sun J, Jiang Q, Zhang X, Shan K, Liu B, Zhao C. Mesoporous silica nanoparticles as a delivery system for improving antiangiogenic therapy Mesoporous silica nanoparticles as a delivery system for improving antiangiogenic therapy. 2023; https:\/\/doi.org\/10.2147\/IJN.S195504","DOI":"10.2147\/IJN.S195504"},{"key":"3426_CR97","doi-asserted-by":"publisher","unstructured":"Lai CF, Shiau FJ. Hydrogel Contact Lenses Embedded with Amine-Functionalized Large-Pore Mesoporous Silica Nanoparticles with Extended Hyaluronic Acid Release. Nanomaterials 2023, Vol 13, [Internet]. Multidisciplinary Digital Publishing Institute; 2023 [cited 2026 Apr 16];13. https:\/\/doi.org\/10.3390\/NANO13172441","DOI":"10.3390\/NANO13172441"},{"key":"3426_CR98","doi-asserted-by":"publisher","unstructured":"Lai CF, Shiau FJ. Hydrogel Contact Lenses Embedded with Amine-Functionalized Large-Pore Mesoporous Silica Nanoparticles with Extended Hyaluronic Acid Release. Nanomaterials (Basel) [Internet]. Nanomaterials (Basel); 2023 [cited 2026 Mar 29];13. https:\/\/doi.org\/10.3390\/nano13172441","DOI":"10.3390\/nano13172441"},{"key":"3426_CR99","doi-asserted-by":"publisher","unstructured":"Wu M, Wang S, Wang Y, Zhang F, Shao T. Targeted delivery of mitomycin C-loaded and LDL-conjugated mesoporous silica nanoparticles for inhibiting the proliferation of pterygium subconjunctival fibroblasts. Exp Eye Res. Elsevier Ltd; 2020;197:108124. https:\/\/doi.org\/10.1016\/j.exer.2020.108124","DOI":"10.1016\/j.exer.2020.108124"},{"key":"3426_CR100","doi-asserted-by":"publisher","unstructured":"L\u00e9rida-Viso A, Estepa-Fern\u00e1ndez A, Garc\u00eda-Fern\u00e1ndez A, Mart\u00ed-Centelles V, Mart\u00ednez-M\u00e1\u00f1ez R. Biosafety of mesoporous silica nanoparticles; towards clinical translation. Adv Drug Deliv Rev [Internet]. Elsevier; 2023 [cited 2026 Feb 8];201:115049. https:\/\/doi.org\/10.1016\/j.addr.2023.115049","DOI":"10.1016\/j.addr.2023.115049"},{"key":"3426_CR101","doi-asserted-by":"publisher","unstructured":"Croissant JG, Brinker CJ. Biodegradable Silica-Based Nanoparticles: Dissolution Kinetics and Selective Bond Cleavage. Enzymes (Essen) [Internet]. Academic Press; 2018 [cited 2026 Feb 8];43:181\u2013214. https:\/\/doi.org\/10.1016\/bs.enz.2018.07.008","DOI":"10.1016\/bs.enz.2018.07.008"},{"key":"3426_CR102","doi-asserted-by":"publisher","unstructured":"Poscher V, Salinas Y. Trends in Degradable Mesoporous Organosilica-Based Nanomaterials for Controlling Drug Delivery: A Mini Review. Materials 2020, Vol 13, Page 3668 [Internet]. Multidisciplinary Digital Publishing Institute; 2020 [cited 2026 Feb 8];13:3668. https:\/\/doi.org\/10.3390\/MA13173668","DOI":"10.3390\/MA13173668"},{"key":"3426_CR103","doi-asserted-by":"publisher","unstructured":"Li X, Gao F, Dong Y, Li X. Strategies to Regulate the Degradability of Mesoporous Silica-based Nanoparticles for Biomedical Applications. 101142\/S1793292019300081 [Internet]. World Scientific Publishing Company ; 2019 [cited 2026 Feb 8];14. https:\/\/doi.org\/10.1142\/S1793292019300081","DOI":"10.1142\/S1793292019300081"},{"key":"3426_CR104","doi-asserted-by":"publisher","unstructured":"Hosseinpour S, Walsh LJ, Xu C. Biomedical application of mesoporous silica nanoparticles as delivery systems: A biological safety perspective. J Mater Chem B [Internet]. Royal Society of Chemistry; 2020 [cited 2026 Feb 8];8:9863\u201376. https:\/\/doi.org\/10.1039\/d0tb01868f","DOI":"10.1039\/d0tb01868f"},{"key":"3426_CR105","doi-asserted-by":"publisher","unstructured":"Croissant JG, Fatieiev Y, Almalik A, Khashab NM, Almalik AM. Article type: Review Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications. [cited 2026 Feb 8]; https:\/\/doi.org\/10.1002\/adhm.201700831","DOI":"10.1002\/adhm.201700831"},{"key":"3426_CR106","doi-asserted-by":"publisher","unstructured":"Ultimo A, Orzaez M, Santos-Martinez MJ, Mart\u00ednez-M\u00e1\u00f1ez R, Marcos MD, Sancen\u00f3n F, et al. High-Capacity Mesoporous Silica Nanocarriers of siRNA for Applications in Retinal Delivery. Int J Mol Sci [Internet]. MDPI; 2023 [cited 2026 Feb 8];24:2753. https:\/\/doi.org\/10.3390\/ijms24032753","DOI":"10.3390\/ijms24032753"},{"key":"3426_CR107","doi-asserted-by":"publisher","unstructured":"Manuscript A. file:\/\/\/C:\/Users\/hp\/Desktop\/study material\/Ph.D Nirma\/MSNs\/research + review\/occular MSNs\/2017 Mesoporous Silica Nanoparticles for Drug Delivery Current Insights.pdf. 2020; https:\/\/doi.org\/10.1039\/D0NR03208E","DOI":"10.1039\/D0NR03208E"},{"key":"3426_CR108","doi-asserted-by":"publisher","unstructured":"Park JH, Kim DJ, Park CY. Retinal cytotoxicity of silica and titanium dioxide nanoparticles. Toxicol Res (Camb) [Internet]. Oxford University Press; 2021 [cited 2026 Feb 8];11:88. https:\/\/doi.org\/10.1093\/toxres\/tfab117","DOI":"10.1093\/toxres\/tfab117"},{"key":"3426_CR109","doi-asserted-by":"publisher","unstructured":"Guo C, Yang M, Jing L, Wang J, Yu Y, Li Y, et al. Amorphous silica nanoparticles trigger vascular endothelial cell injury through apoptosis and autophagy via reactive oxygen species-mediated MAPK\/Bcl-2 and PI3K\/Akt\/mTOR signaling. Int J Nanomedicine [Internet]. Dove Medical Press Ltd.; 2016 [cited 2026 Feb 8];11:5257. https:\/\/doi.org\/10.2147\/IJN.S112030","DOI":"10.2147\/IJN.S112030"},{"key":"3426_CR110","doi-asserted-by":"publisher","unstructured":"Park JH, Kim DJ, Park CY. Retinal cytotoxicity of silica and titanium dioxide nanoparticles. Toxicol Res (Camb) [Internet]. Toxicol Res (Camb); 2021 [cited 2026 Feb 8];11:88\u2013100. https:\/\/doi.org\/10.1093\/toxres\/tfab117","DOI":"10.1093\/toxres\/tfab117"},{"key":"3426_CR111","doi-asserted-by":"publisher","unstructured":"Yu Y, Duan J, Yu Y, Li Y, Liu X, Zhou X, et al. Silica nanoparticles induce autophagy and autophagic cell death in HepG2 cells triggered by reactive oxygen species. J Hazard Mater [Internet]. J Hazard Mater; 2014 [cited 2026 Feb 8];270:176\u201386. https:\/\/doi.org\/10.1016\/j.jhazmat.2014.01.028","DOI":"10.1016\/j.jhazmat.2014.01.028"},{"key":"3426_CR112","doi-asserted-by":"publisher","unstructured":"Kim M, Park J, Jeong H, Hong J, Choi WS, Park CY. An Evaluation of the in vivo Safety of Nonporous Silica Nanoparticles\u202f: Ocular Topical Administration versus Oral Administration. Sci Rep. Springer US; 2017;1\u20138. https:\/\/doi.org\/10.1038\/s41598-017-08843-9","DOI":"10.1038\/s41598-017-08843-9"},{"key":"3426_CR113","doi-asserted-by":"publisher","unstructured":"Yang C, Yang J, Lu A, Gong J, Yang Y, Lin X, et al. Nanoparticles in ocular applications and their potential toxicity. Front Mol Biosci. 2022;9:1\u201318. https:\/\/doi.org\/10.3389\/fmolb.2022.931759","DOI":"10.3389\/fmolb.2022.931759"},{"key":"3426_CR114","doi-asserted-by":"publisher","unstructured":"Mohammadpour R, Yazdimamaghani M, Cheney DL, Jedrzkiewicz J, Ghandehari H. Subchronic toxicity of silica nanoparticles as a function of size and porosity. Journal of Controlled Release [Internet]. Elsevier; 2019 [cited 2026 Jan 18];304:216\u201332. https:\/\/doi.org\/10.1016\/J.JCONREL.2019.04.041","DOI":"10.1016\/J.JCONREL.2019.04.041"},{"key":"3426_CR115","doi-asserted-by":"publisher","unstructured":"Sun D, Gong L, Xie J, Gu X, Li Y, Cao Q, et al. Toxicity of silicon dioxide nanoparticles with varying sizes on the cornea and protein corona as a strategy for therapy. Sci Bull (Beijing) [Internet]. Elsevier; 2018 [cited 2026 Jan 20];63:907\u201316. https:\/\/doi.org\/10.1016\/J.SCIB.2018.05.037","DOI":"10.1016\/J.SCIB.2018.05.037"},{"key":"3426_CR116","doi-asserted-by":"publisher","unstructured":"Chen X, Zhu S, Hu X, Sun D, Yang J, Yang C, et al. Toxicity and mechanism of mesoporous silica nanoparticles in eyes. Nanoscale [Internet]. Nanoscale; 2020 [cited 2026 Jan 17];12:13637\u201353. https:\/\/doi.org\/10.1039\/D0NR03208E","DOI":"10.1039\/D0NR03208E"},{"key":"3426_CR117","doi-asserted-by":"publisher","unstructured":"Kim M, Park JH, Jeong H, Hong J, Choi WS, Lee BH, et al. An Evaluation of the in vivo Safety of Nonporous Silica Nanoparticles: Ocular Topical Administration versus Oral Administration. Scientific Reports 2017 7:1 [Internet]. Nature Publishing Group; 2017 [cited 2026 Jan 18];7:8238-. https:\/\/doi.org\/10.1038\/s41598-017-08843-9","DOI":"10.1038\/s41598-017-08843-9"},{"key":"3426_CR118","doi-asserted-by":"publisher","unstructured":"Sun Y, Huffman K, Freeman WR, Sailor MJ, Cheng L. Intravitreal safety profiles of sol-gel mesoporous silica microparticles and the degradation product (Si(OH)4). Drug Deliv [Internet]. Taylor and Francis Ltd; 2020 [cited 2026 Jan 20];27:703. https:\/\/doi.org\/10.1080\/10717544.2020.1760401","DOI":"10.1080\/10717544.2020.1760401"},{"key":"3426_CR119","doi-asserted-by":"publisher","unstructured":"Paiva MRB, Andrade GF, Dourado LFN, Castro BFM, Fialho SL, Sousa EMB, et al. Surface functionalized mesoporous silica nanoparticles for intravitreal application of tacrolimus. J Biomater Appl [Internet]. J Biomater Appl; 2021 [cited 2026 Jan 18];35:1019\u201333. https:\/\/doi.org\/10.1177\/0885328220977605","DOI":"10.1177\/0885328220977605"},{"key":"3426_CR120","unstructured":"WO2024047230A1 - Ophthalmic compositions - Google Patents [Internet]. [cited 2026 Apr 16]. https:\/\/patents.google.com\/patent\/WO2024047230A1\/en?oq=WO2024047230A1. Accessed 16 Apr 2026."},{"key":"3426_CR121","unstructured":"US20220096373A1 - Bandage Contact Lens for Sustained Drug Delivery - Google Patents [Internet]. [cited 2026 Apr 16]. https:\/\/patents.google.com\/patent\/US20220096373A1\/en?oq=US+2022%2f0096373+A1. Accessed 16 Apr 2026."},{"key":"3426_CR122","unstructured":"US8257745B2 - Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs - Google Patents [Internet]. [cited 2026 Apr 16]. https:\/\/patents.google.com\/patent\/US8257745B2\/en?oq=US8257745B2. Accessed 16 Apr 2026."},{"key":"3426_CR123","doi-asserted-by":"publisher","unstructured":"Djayanti K, Maharjan P, Cho KH, Jeong S, Kim MS, Shin MC, et al. Mesoporous Silica Nanoparticles as a Potential Nanoplatform: Therapeutic Applications and Considerations. International Journal of Molecular Sciences 2023, Vol 24, [Internet]. Multidisciplinary Digital Publishing Institute; 2023 [cited 2026 Jan 19];24. https:\/\/doi.org\/10.3390\/IJMS24076349","DOI":"10.3390\/IJMS24076349"},{"key":"3426_CR124","doi-asserted-by":"publisher","unstructured":"Almatroudi A, Almatroudi A. Advances in Mesoporous Silica and Hybrid Nanoparticles for Drug Delivery: Synthesis, Functionalization, and Biomedical Applications. Pharmaceutics 2025, Vol 17, [Internet]. Multidisciplinary Digital Publishing Institute; 2025 [cited 2026 Jan 19];17. https:\/\/doi.org\/10.3390\/PHARMACEUTICS17121602","DOI":"10.3390\/PHARMACEUTICS17121602"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03426-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03426-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03426-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:09:03Z","timestamp":1780502943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03426-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":124,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["3426"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03426-2","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used Quillbot and Grammarly services in order to improve scientific writing. After using this tool or service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of Generative AI and AI-assisted Technologies in the Writing Process"}},{"value":"The authors declare that they have no conflict of interest in publishing this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors used Quillbot and Grammarly service in order to improve scientific writing and English language after using this tool or service.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"A.I. Disclosure statement"}}],"article-number":"197"}}